Desmopressin AcetateThird Party Manufacturing in India

Desmopressin Acetate works by selectively binding to V2 receptors in the basolateral membrane of the renal collecting ducts. It stimulates adenylate cyclase activity to increase cAMP levels, triggering the insertion of aquaporin-2 water channels to help the body reabsorb free water and concentrate urine. Unlike native vasopressin, it displays minimal affinity for vascular V1 receptors, avoiding unwanted pressor effects or significant vasoconstriction. It is highly effective and well-tolerated for targeted antidiuretic and hematologic clinical protocols.

Therapeutic Uses

• Central Diabetes Insipidus: Provides effective long-term management of polyuria and polydipsia associated with vasopressin deficiencies.
• Mild Hemophilia A: Elevates systemic levels of clotting Factor VIII and von Willebrand factor before minor surgical interventions.
• Von Willebrand Disease Type 1: Restores functional hemostasis in patients during acute bleeding episodes or surgical prophylaxis.

Why Manufacturers Choose Desmopressin Acetate

Specialized buyers prioritize Desmopressin Acetate third party manufacturing in India due to the high barrier to entry and steady global demand for advanced hormonal parenterals. Our partner facilities are WHO-GMP certified, applying cutting-edge peptide synthesis and aseptic filling processes. Celesta provides highly accurate chemical tracking and reliable standard compliance under CAS identification rules.